The company’s equity raise to recapitalise its balance sheet was oversubscribed, raising $23.9m.
The listed probiotic maker will come out of a trading halt this morning after telling the market it would take legal action.
Trigger for $700m capital raise was resolution of Iplex crisis, not disappointing bids for residential assets, says incoming CEO.
New York-based hedge fund Ampfield Management has reduced its holding in the transport tech company.
Cash will pay down debt and reduce pressure to sell assets, company said.
Exchange says work on rebrand planning began some years ago, but design and implementation only kicked off this year.
Analysts at Forsyth Barr drop recommendation to ‘neutral’ from ‘outperform’.
One analyst sees an 80% chance of ComCom approval for Contact’s Manawa buy, another sees 50%. Both see political point scoring as the main risk.
What’s causing a rapid upsurge in the cancer diagnostic company’s share price over the past week?
Company tells shareholders its brand is strong and resilient – with upside potential – despite some negative Google reviews.